GSAT 10-Q report for 2026-03-31

Globalstar, Inc. (GSAT) filed its Form 10‑Q for the quarter ended March 31, 2026. The unaudited condensed consolidated statements show total revenue of $70,064,000, service revenue of $66,701,000, subscriber equipment sales of $3,363,000, net loss of $17,420,000, cash and cash equivalents of $358,448,000, total assets of $2,377,467,000 and total liabilities of $2,034,651,000. The filing discloses pending Mergers with Amazon and reiterates extensive forward‑looking risk factors. As of May 1, 2026, 128,788,931 shares of common stock and 149,425 shares of preferred stock were outstanding.

This 10‑Q filing is primarily the company's unaudited interim consolidated financial statements and standard SEC cover/forward‑looking disclosures. It confirms key balance sheet and income statement figures for Q1 2026 (revenue, net loss, cash, assets, liabilities and shares outstanding) and reiterates material forward‑looking risk items tied to the disclosed pending Mergers with Amazon. The document contains no new MD&A narrative, guidance updates, material event disclosures beyond the merger references, or other incremental operating metrics that would create a high‑confidence, actionable catalyst. Use the filing to verify the company’s reported results and capital structure; further analysis should be based on the full 10‑Q detail (MD&A, liquidity discussion, notes) and subsequent filings.

This excerpt is only the cover page/header of Sleep Number’s Form 10‑Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high‑confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As‑is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

This excerpt is essentially the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk‑factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital‑structure/dilution considerations around the listed warrant.

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover‑page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk‑factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.